• SASL is an interdisciplinary group of Swiss scientists, clinicians and translational researchers interested in liver biology and disease. Our mission is to promote research, to disseminate knowledge and to prevent and cure liver disease.

  • Download the new SASL Expert Opinion Statement on Management of Hepatocellular Carcinoma

  • Corona Virus Pandemic:
    recommendations for patients with liver diseases

  • Corona Virus Pandemie:
    Empfehlungen für Patienten mit Lebererkrankungen

  • Pandémie de SRAS-CoV-2:
    Recommandations pour les patients atteints d'une maladie du foie

  • Pandemia Coronavirus:
    Raccomandazioni per i pazienti con malattie del fegato

  • New regulations for financial support of SASL studies

  • Download the free SASL HCV Advisor app for your smartphone

SASL School of Hepatology

Upcoming Courses:
SASL School Number 34

Monday, 13 Dec 2021, 1730h-1900h
SASL hepatology news. David Semela, St. Gallen
Pediatric liver disease. Valerie McLin, HUG Geneva
Management of portal hypertension - news from BAVENO VII. Annalisa Berzgotti, Inselspital Bern


MELD score

Calculates the Model of Endstage Liver Disease Score

Alcoholic hepatitis score calculator

Set of calculators for alcoholic hepatitis

Lille model

A tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids

VOCAL-Penn Cirrhosis Surgical Risk Score

VOCAL-Penn predicts post-operative mortality for patients with cirrhosis


Causality assessment of adverse reactions to drugs


Homeostasis model assessment of insulin resistance

FIPS (Freiburg Index of Post-TIPS Survival)

FIPS is a tool based on age, total bilirubin, serum creatinine and albumin for risk stratification before TIPS implantation (J Hepatol 2021;74,1362-1372)

more calculators

Upcoming Congresses

13th Challenges in Viral Hepatitis and Liver Disease

13 Jan 2022 - 13 Jan 2022, auditoire Jequeier Doge et visiconference

Member Payment

SASL Zürich
PostFinance: 30-8596-4
IBAN: CH85 09000000 300085964